$ULBI
ULTRALIFE CORP

2017 Q3 Form 10-Q Financial Statement

#000143774917013611 Filed on August 03, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q2
Revenue $19.94M $20.37M
YoY Change 1.57% 7.47%
Cost Of Revenue $13.72M $14.47M
YoY Change 0.62% 10.5%
Gross Profit $6.221M $5.900M
YoY Change 3.74% 0.7%
Gross Profit Margin 31.2% 28.96%
Selling, General & Admin $3.714M $3.976M
YoY Change 6.05% 7.23%
% of Gross Profit 59.7% 67.39%
Research & Development $1.185M $1.425M
YoY Change -12.68% 6.82%
% of Gross Profit 19.05% 24.15%
Depreciation & Amortization $507.0K $576.0K
YoY Change -4.88% -1.03%
% of Gross Profit 8.15% 9.76%
Operating Expenses $4.899M $5.401M
YoY Change 0.82% 7.12%
Operating Profit $1.322M $499.0K
YoY Change 16.17% -38.92%
Interest Expense -$40.00K -$60.00K
YoY Change -20.0% 0.0%
% of Operating Profit -3.03% -12.02%
Other Income/Expense, Net -$8.000K $38.00K
YoY Change -140.0% -58.7%
Pretax Income $1.273M $475.0K
YoY Change 14.89% -43.79%
Income Tax $179.0K $33.00K
% Of Pretax Income 14.06% 6.95%
Net Earnings $1.094M $446.0K
YoY Change 7.36% -43.4%
Net Earnings / Revenue 5.49% 2.19%
Basic Earnings Per Share $0.07 $0.03
Diluted Earnings Per Share $0.07 $0.03
COMMON SHARES
Basic Shares Outstanding 15.51K 15.26M
Diluted Shares Outstanding 15.85K 15.42M

Balance Sheet

Concept 2017 Q3 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.90M $3.100M
YoY Change 122.39% -80.38%
Cash & Equivalents $14.93M $3.120M
Short-Term Investments
Other Short-Term Assets $1.800M $2.400M
YoY Change -35.71% 84.62%
Inventory $24.49M $26.55M
Prepaid Expenses
Receivables $13.54M $13.74M
Other Receivables $0.00 $200.0K
Total Short-Term Assets $54.80M $45.99M
YoY Change 16.14% -12.57%
LONG-TERM ASSETS
Property, Plant & Equipment $7.833M $8.858M
YoY Change -8.4% -6.76%
Goodwill $20.22M $20.18M
YoY Change -0.2% 22.82%
Intangibles $7.169M
YoY Change
Long-Term Investments
YoY Change
Other Assets $143.0K $74.00K
YoY Change 95.89% -63.0%
Total Long-Term Assets $35.46M $37.31M
YoY Change -2.49% 22.99%
TOTAL ASSETS
Total Short-Term Assets $54.80M $45.99M
Total Long-Term Assets $35.46M $37.31M
Total Assets $90.27M $83.30M
YoY Change 8.03% 0.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.647M $6.654M
YoY Change 20.94% 3.97%
Accrued Expenses $3.800M $4.200M
YoY Change -24.0% 2.44%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $831.0K
YoY Change
Total Short-Term Liabilities $11.87M $11.87M
YoY Change 3.47% 12.01%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $27.00K $28.00K
YoY Change -3.57% -72.0%
Total Long-Term Liabilities $27.00K $28.00K
YoY Change -3.57% -72.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.87M $11.87M
Total Long-Term Liabilities $27.00K $28.00K
Total Liabilities $17.52M $17.44M
YoY Change 3.01% 15.51%
SHAREHOLDERS EQUITY
Retained Earnings -$87.79M -$93.31M
YoY Change -4.87%
Common Stock $1.957M $1.920M
YoY Change 1.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $4.016M $4.010M
Shareholders Equity $72.91M $66.02M
YoY Change
Total Liabilities & Shareholders Equity $90.27M $83.30M
YoY Change 8.03% 0.48%

Cashflow Statement

Concept 2017 Q3 2016 Q2
OPERATING ACTIVITIES
Net Income $1.094M $446.0K
YoY Change 7.36% -43.4%
Depreciation, Depletion And Amortization $507.0K $576.0K
YoY Change -4.88% -1.03%
Cash From Operating Activities $1.290M $2.080M
YoY Change -70.48% 30.82%
INVESTING ACTIVITIES
Capital Expenditures -$260.0K -$820.0K
YoY Change 160.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$260.0K -$820.0K
YoY Change 550.0% 95.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 250.0K -870.0K
YoY Change -134.25% -84.27%
NET CHANGE
Cash From Operating Activities 1.290M 2.080M
Cash From Investing Activities -260.0K -820.0K
Cash From Financing Activities 250.0K -870.0K
Net Change In Cash 1.280M 390.0K
YoY Change -64.44% -108.94%
FREE CASH FLOW
Cash From Operating Activities $1.290M $2.080M
Capital Expenditures -$260.0K -$820.0K
Free Cash Flow $1.550M $2.900M
YoY Change -65.32% 45.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
104000
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
137000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1060916
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
996583
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
274000
CY2017Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1055097
CY2016Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1144076
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1055097
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmount
1177076
CY2017Q3 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
13400
CY2016Q2 ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
32800
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
13400
ulbi Dilutive Securities Included In Computation Of Earnings Per Share Amount Restricted Stock
DilutiveSecuritiesIncludedInComputationOfEarningsPerShareAmountRestrictedStock
32800
CY2017Q3 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
49000
CY2016Q2 ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
24000
ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
142000
ulbi Interest And Other Finance Costs
InterestAndOtherFinanceCosts
137000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7647000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7292000
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13543000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13179000
CY2017Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
386000
CY2016Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
172000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58240000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
57194000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2327000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3080000
CY2017Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
179519000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
178163000
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
356000
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
169000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
396000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
350000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
273000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
277000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
33000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
37000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
209000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1060916
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
963583
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
1957000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1932000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1588000
CY2015Q4 us-gaap Cash
Cash
14393000
CY2016Q2 us-gaap Cash
Cash
3120000
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
4304000
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-11273000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Assets
Assets
84744000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
54803000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
49420000
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.07
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.07
us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
1274000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1053000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
41204000
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19567642
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19324723
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15551890
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15308971
CY2017Q3 us-gaap Assets
Assets
90265000
CY2016Q2 us-gaap Assets
Assets
83298000
CY2017Q3 us-gaap Cash
Cash
14933000
CY2016Q4 us-gaap Cash
Cash
10629000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3502000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
44000
CY2017Q3 us-gaap Cost Of Revenue
CostOfRevenue
13718000
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
14471000
us-gaap Cost Of Revenue
CostOfRevenue
28863000
us-gaap Cost Of Revenue
CostOfRevenue
28899000
CY2017Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6000
CY2016Q2 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
13000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
28000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
17000
CY2017Q3 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
130000
CY2016Q2 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-41000
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
151000
us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-14000
CY2017Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
CY2016Q2 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-7000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
8000
CY2017Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
40000
CY2016Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
68000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
79000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
110000
CY2017Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
94000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
94000
CY2017Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5615000
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5538000
CY2017Q3 us-gaap Depreciation
Depreciation
507000
CY2016Q2 us-gaap Depreciation
Depreciation
576000
us-gaap Depreciation
Depreciation
1010000
us-gaap Depreciation
Depreciation
1165000
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
123000
us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-26000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.088
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.143
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1875000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1258000
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
616000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9026000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8796000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
478000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-2093000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
274000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1053000
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16195000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15990000
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7169000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7194000
CY2017Q3 us-gaap Goodwill
Goodwill
20223000
CY2016Q4 us-gaap Goodwill
Goodwill
19965000
CY2015Q4 us-gaap Goodwill
Goodwill
16283000
CY2016Q2 us-gaap Goodwill
Goodwill
20175000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
4407000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-314000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-438000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
258000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-201000
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
228000
CY2017Q3 us-gaap Gross Profit
GrossProfit
6221000
CY2016Q2 us-gaap Gross Profit
GrossProfit
5900000
us-gaap Gross Profit
GrossProfit
13111000
us-gaap Gross Profit
GrossProfit
12305000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1273000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
475000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3021000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
844000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3021000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
844000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
179000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
33000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-79000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-95000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
904000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
762000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-246000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-462000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
339705
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
160732
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
291062
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
255479
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7169000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7194000
CY2017Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
41000
CY2016Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
62000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
109000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
163000
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8989000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7988000
CY2017Q3 us-gaap Inventory Net
InventoryNet
24490000
CY2016Q4 us-gaap Inventory Net
InventoryNet
23456000
CY2017Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13806000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
14482000
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1695000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
986000
CY2017Q3 us-gaap Liabilities
Liabilities
17516000
CY2016Q4 us-gaap Liabilities
Liabilities
16884000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90265000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
84744000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11874000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11328000
CY2015Q2 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
42000000
CY2017Q3 us-gaap Minority Interest
MinorityInterest
-164000
CY2016Q4 us-gaap Minority Interest
MinorityInterest
-170000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
989000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
300000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-836000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10745000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
4028000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-802000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
1094000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
446000
us-gaap Net Income Loss
NetIncomeLoss
2749000
us-gaap Net Income Loss
NetIncomeLoss
745000
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-22000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
4899000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
5401000
us-gaap Operating Expenses
OperatingExpenses
9948000
us-gaap Operating Expenses
OperatingExpenses
11324000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1322000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
499000
us-gaap Operating Income Loss
OperatingIncomeLoss
3163000
us-gaap Operating Income Loss
OperatingIncomeLoss
981000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
3030000
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-2198000
CY2017Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
248000
CY2016Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
61000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
989000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
75000
CY2016Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
172000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
143000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72000
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
494000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-422000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
753000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-701000
CY2017Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1966000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2606000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
38000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
607000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
9857000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
836000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
888000
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1754000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2079000
CY2015Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
192000
CY2017Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
163000
CY2016Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
176000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
38000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
42000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
29000
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
26000
us-gaap Profit Loss
ProfitLoss
2755000
us-gaap Profit Loss
ProfitLoss
723000
CY2017Q3 us-gaap Profit Loss
ProfitLoss
1094000
CY2016Q2 us-gaap Profit Loss
ProfitLoss
442000
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
66073000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65193000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7833000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7999000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.10
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90542000
CY2017Q3 us-gaap Revenues
Revenues
19939000
CY2016Q2 us-gaap Revenues
Revenues
20371000
us-gaap Revenues
Revenues
41974000
us-gaap Revenues
Revenues
41204000
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3714000
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3976000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7625000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8243000
us-gaap Share Based Compensation
ShareBasedCompensation
396000
us-gaap Share Based Compensation
ShareBasedCompensation
350000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1185000
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1425000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2323000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3081000
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
83000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
77000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87793000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1273909
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
209399
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
244750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.47
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3929000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2323581
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2116013
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.22
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2706000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
6.17
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
3658000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2000545
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.07
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.20
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.60
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y7D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y113D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y58D
CY2017Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
5.08
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
242919
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
72913000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
68030000
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
72749000
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
67860000
CY2017Q3 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
18443000
CY2016Q4 us-gaap Treasury Stock Carrying Basis
TreasuryStockCarryingBasis
18443000
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4015752
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
4015752
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
2592095
CY2016Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
149904
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
149904
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10480000
CY2016Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
603000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
603000
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
340000
CY2016Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
161000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
291000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
255000
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15850000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15419000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15752000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15545000
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15510000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15258000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15461000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15290000

Files In Submission

Name View Source Status
0001437749-17-013611-index-headers.html Edgar Link pending
0001437749-17-013611-index.html Edgar Link pending
0001437749-17-013611.txt Edgar Link pending
0001437749-17-013611-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ulbi-20170702.xml Edgar Link completed
ulbi-20170702.xsd Edgar Link pending
ulbi-20170702_cal.xml Edgar Link unprocessable
ulbi-20170702_def.xml Edgar Link unprocessable
ulbi-20170702_lab.xml Edgar Link unprocessable
ulbi-20170702_pre.xml Edgar Link unprocessable
ulbi20170625_10q.htm Edgar Link pending
ulbi20170625_10qimg001.jpg Edgar Link pending